Consolidated Statement of Cash Flows - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net loss		$ (67,843)	$ (91,549)
Adjustments to reconcile net loss to net cash used in operations:
Share-based compensation		30,489	34,334
Depreciation and amortization		6,658	6,954
Amortization of right-of-use assets		2,654	3,153
Loss on impairment of long lived assets		1,052	599
Allowance for credit losses		238	270
Change in fair value of warrant liabilities		(9,424)	6,465
Change in fair value of contingent liability	[1]	0	2,545
Other		(10)	(625)
Changes in operating assets and liabilities:
Accounts receivable		(877)	(792)
Prepaid expenses and other assets		(1,340)	2,018
Accounts payable		284	(1,216)
Accrued expenses and other liabilities		(2,267)	2,805
Accrued compensation and benefits		2,426	(2,267)
Operating lease liabilities		(2,573)	(4,150)
Net cash used in operating activities		(40,533)	(41,456)
Cash flows from investing activities:
Receipts of term deposit maturities		6,559	2,115
Purchases of property and equipment		(792)	(527)
Purchases of term deposit		0	(9,748)
Capitalized internal-use software development costs		(296)	0
Net cash provided by (used in) investing activities		5,471	(8,160)
Cash flows from financing activities:
Proceeds from exercise of options		528	710
Taxes withheld and paid related to net share settlement of equity awards		(4,419)	(653)
Net cash (used in) provided by financing activities		(3,891)	57
Effect of changes in currency exchange rates on cash and cash equivalents		(575)	378
Net decrease in cash and cash equivalents		(39,528)	(49,181)
Cash, cash equivalents and restricted cash, beginning of the period		145,784	194,965
Cash, cash equivalents and restricted cash, end of the period		106,256	145,784
Reconciliation of cash, cash equivalents and restricted cash to the amounts reported within the consolidated balance sheets
Cash and cash equivalents		105,140	144,722
Restricted cash		1,116	1,062
Total cash, cash equivalents and restricted cash, end of the period		106,256	145,784
Supplemental disclosures of cash flow information:
Cash paid for taxes		913	145
Supplemental disclosure of non-cash investing and financing activities:
Lease liabilities arising from obtaining right-of-use assets		4,506	1,755
Vesting of early exercised stock options and restricted stock awards		144	262
Purchase of property and equipment accrued and not yet paid		20	250
Capitalized internal-use software development costs accrued and not yet paid		$ 56	$ 0

[1] The change in fair value of contingent liability in connection with the modification of Junior Preferred Stock Warrants (into the December 2023 Warrants) is recorded in the consolidated statement of operations within General and administrative expense. See Note 3, "Fair Value Measurements," for additional information.